AU2001258859A1 - Pralmorelin-containing nasal drop preparations - Google Patents

Pralmorelin-containing nasal drop preparations

Info

Publication number
AU2001258859A1
AU2001258859A1 AU2001258859A AU5885901A AU2001258859A1 AU 2001258859 A1 AU2001258859 A1 AU 2001258859A1 AU 2001258859 A AU2001258859 A AU 2001258859A AU 5885901 A AU5885901 A AU 5885901A AU 2001258859 A1 AU2001258859 A1 AU 2001258859A1
Authority
AU
Australia
Prior art keywords
pralmorelin
alanyl
preparation
nasal drop
containing nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001258859A
Other languages
English (en)
Inventor
Yasutomi Kato
Hirokuni Kogetsu
Kiyoshi Maruyama
Akiko Ochiai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Publication of AU2001258859A1 publication Critical patent/AU2001258859A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001258859A 2000-05-29 2001-05-29 Pralmorelin-containing nasal drop preparations Abandoned AU2001258859A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000158676A JP3498041B2 (ja) 2000-05-29 2000-05-29 プラルモレリン含有点鼻用製剤
JP2000-158676 2000-05-29
PCT/JP2001/004503 WO2001091782A1 (fr) 2000-05-29 2001-05-29 Preparations de gouttes nasales contenant de la pralmoreline

Publications (1)

Publication Number Publication Date
AU2001258859A1 true AU2001258859A1 (en) 2001-12-11

Family

ID=18663108

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001258859A Abandoned AU2001258859A1 (en) 2000-05-29 2001-05-29 Pralmorelin-containing nasal drop preparations

Country Status (7)

Country Link
US (1) US7008927B2 (ja)
EP (1) EP1297838B1 (ja)
JP (1) JP3498041B2 (ja)
AT (1) ATE408413T1 (ja)
AU (1) AU2001258859A1 (ja)
DE (1) DE60135845D1 (ja)
WO (1) WO2001091782A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
US7452868B2 (en) * 2005-03-11 2008-11-18 Indevus Pharmaceuticals, Inc. Controlled release formulations of octreotide
CN101583274A (zh) * 2006-12-29 2009-11-18 雷文斯治疗公司 使用反向序列hiv-tat多肽的运输分子
WO2009158412A2 (en) * 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
JP5536053B2 (ja) * 2008-06-25 2014-07-02 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド． 離型剤を有するオクトレオチドインプラント

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
IT1222395B (it) * 1987-07-30 1990-09-05 Pierrel Spa Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
JP3179538B2 (ja) 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
WO1995011042A1 (fr) * 1993-10-21 1995-04-27 Hisamitsu Pharmaceutical Co., Inc. Composition administree par voie nasale et preparation contenant celle-ci
JP2660484B2 (ja) * 1994-04-12 1997-10-08 株式会社ミドリ十字 ヒト尿性トリプシンインヒビター含有液状製剤
JPH1045619A (ja) * 1996-07-31 1998-02-17 Kaken Pharmaceut Co Ltd 成長ホルモン分泌促進ペプチド含有経口製剤
US5932548A (en) 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease
EP1297839A4 (en) * 2000-06-23 2005-12-07 Kaken Pharma Co Ltd THERAPEUTIC AND PROPHYLACTIC AGENTS FOR CARDIAC INSUFFICIENCY
JP2002053489A (ja) * 2000-08-07 2002-02-19 Kaken Pharmaceut Co Ltd 筋肉増強剤・筋肉減衰の予防・治療剤

Also Published As

Publication number Publication date
ATE408413T1 (de) 2008-10-15
EP1297838B1 (en) 2008-09-17
DE60135845D1 (de) 2008-10-30
US7008927B2 (en) 2006-03-07
WO2001091782A1 (fr) 2001-12-06
JP2001335508A (ja) 2001-12-04
US20030139347A1 (en) 2003-07-24
JP3498041B2 (ja) 2004-02-16
EP1297838A1 (en) 2003-04-02
EP1297838A4 (en) 2003-07-09

Similar Documents

Publication Publication Date Title
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
GB9814172D0 (en) Formulation for inhalation
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
EP1317419A4 (en) CYANOPHENOXYCARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS
WO2002019999A3 (en) Compositions for treating sexual dysfunction, containing an no-donor and an antioxidant
ITMI912024A1 (it) Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
CA2388610A1 (en) Oral transmucosal drug dosage using solid solution
WO2008013929A3 (en) Anti-migraine oral spray formulations and methods
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
WO2005044226A3 (en) Lipid formulations for spontaneous drug encapsulation
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
NZ507203A (en) Use of dexmedetomidine for ICU sedation
IL158155A (en) Use of erythropoietin for the preparation of a medicament to ameliorate chemotherapy-induced toxicity
WO2002000166A3 (en) New compounds useful as antibacterial agents
AU2001258859A1 (en) Pralmorelin-containing nasal drop preparations
WO2001051028A3 (en) Formulations and methods for administration of pharmacologically or biologically active compounds
EP0647616A4 (en) COMPOUND BASED ON ZINC TRANEXAMATE.
CA2406179A1 (en) Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors
DE50105710D1 (de) Pharmazeutische, ramipril enthaltende brauseformulierung
BE2016C017I2 (ja)
SE9900177L (sv) Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
WO2000026185A3 (en) Omeprazole solution and method of using same
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
JPS643123A (en) Remedy for skin inflammation